2KIFOR I, WlLLIAMS G H, VICKERS M A,et al. Tissue angiotensin Ⅱ as a modulator of erectile function. 1-angiotensin peptide content,secretion and effects in the corpus carvernosum[J].J Uro1,1997,157(11):1920-1925.
1[1]1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension.Guidelines subcommittee.J Hypertension,1999,17:151-183.
2[2]Goldberg MR,Bradstreed TE,Mc Willians E,et al.Biochemical effects of losartan,a nonpeptide angiotensin Ⅱ receptor antagonist,on the rennin-angiotensin-aldosterone system in hypertensive patients.J Hypertension,1995,25:37-46.
3[3]Grossman E,Peleg E,Carroll J,et al.Hemodynamic and humoral effects of the angiotensin Ⅱ angionist losartan in essential hypertension.Am J Hypertensions,1994,7:1041-1044.
4[4]Thürmann PA,Kenedi P,Schmidt A,et al.Influence of the angiotensin Ⅱ antagonist,Valsartan on left ventricular hypertrophy in patients with essential hypertension.Circulation,1998,98:2037-2042.
5[5]Jensen J,Lendorf A,Stimpel H,et al.The prevalence and etiology of impotence in 101 male hypertensive outpatients.Am J Hypertens,1999,12:271-275.
6[6]Bansal S.Sexual dysfunction in hypertensive men.A critical review of the literature.J Hypertension,1988,12:1-10.
7[7]Rosen RC.Sexual dysfunction as an obstacle to compliance with antihypertensive therapy.Bood Pressure,1997,6(Suppl 1):47-51.
8[8]Chang SW,Fine R,Siegel D,et al.The impact of diuretic therapy on reported sexual function.Arch Intetn Med,1991,151:2402-2408.
9[9]Fogari R,Zoppi A,Poletti L,et al.Sexual activity in hypertensive men treated with Valsartan or Carvedilol:a crossover study.Am J Hypertens,2001,14:27-31.
10[10]Kifor I,Williams GH,Vickers MA,et al.Tissue angiotensin Ⅱ as a modulator of erectile function.1-Angiotensin peptide content,secretion and effects in the corpus carvernosum.J Urol,1997,157:1920-1925.
